Skip to content
healthcare.dev
Get a free key

Liothyronine Sodium

NDC 0093-2179, Liothyronine Sodium, tablet, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-2179
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211510
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-2179 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM5 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
0093-2179-0100093217901100 TABLET in 1 BOTTLE (0093-2179-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/548d684a-86f5-4e57-9844-d8cf0a84e068

  • NADAC price for package 00093217901

    GET /v1/drugs/nadac/00093217901

Use it

Look up 0093-2179 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-2179 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-2179. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.